Follow
Ayan dey
Ayan dey
MilliporeSigma (Merck KgA Business)
Verified email at milliporesigma.com
Title
Cited by
Cited by
Year
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in …
DP Taufik Momin, Kevinkumar Kansagra, Hardik Patel, Sunil Sharma, Bhumika ...
EClinicalMedicine 38 (https://doi.org/10.1016/j.eclinm.2021.10), 2021
1592021
Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India
PK Akash Khobragade, Suresh Bhate, Vijendra Ramaiah, Shrikant Deshpande ...
The Lancet 399 (10332), 1313-1321, 2022
1492022
Transfusion transmitted leishmaniasis: a case report and review of literature
A Dey, S Singh
Indian Journal of Medical Microbiology 24 (3), 165, 2006
1442006
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models
A Dey, TMC Rajanathan, H Chandra, HPR Pericherla, S Kumar, ...
Vaccine 39 (30), 4108-4116, 2021
1072021
Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood
G Saletti, N Çuburu, JS Yang, A Dey, C Czerkinsky
Nature protocols 8 (6), 1073, 2013
952013
Applications of molecular methods for Leishmania control
S Singh, A Dey, R Sivakumar
Expert review of molecular diagnostics 5 (2), 251-265, 2005
742005
Evaluation of toxicity & therapeutic efficacy of a new liposomal formulation of amphotericin B in a mouse model
J Mishra, A Dey, N Singh, R Somvanshi, S Singh
The Indian journal of medical research 137 (4), 767, 2013
482013
Leishmania-HIV co-infection: an emerging problem in India
NS Redhu, A Dey, V Balooni, S Singh
Aids 20 (8), 1213-1215, 2006
422006
Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India
A Dey, S Singh
Infection, Genetics and Evolution 7 (2), 219-222, 2007
392007
Expression and characterization of a recombinant kinesin antigen from an old Indian strain (DD8) of Leishmania donovani and comparing it with a commercially available antigen …
R Sivakumar, A Dey, P Sharma, S Singh
Infection, genetics and evolution 8 (3), 313-322, 2008
332008
Influence of maternal and socioeconomic factors on breast milk fatty acid composition in urban, low‐income families
U Nayak, S Kanungo, D Zhang, E Ross Colgate, MP Carmolli, A Dey, ...
Maternal & child nutrition 13 (4), 2017
312017
Human circulating antibody-producing B cell as a predictive measure of mucosal immunity to poliovirus
A Dey, NA Molodecky, H Verma, P Sharma, JS Yang, G Saletti, M Ahmad, ...
PloS one 11 (1), e0146010, 2016
292016
The Severe Typhoid Fever in Africa Program: Study Design and Methodology to Assess Disease Severity, Host Immunity, and Carriage Associated With Invasive Salmonellosis
SE Park, T Toy, LM Cruz Espinoza, U Panzner, OD Mogeni, J Im, ...
Clinical Infectious Diseases 69 (Supplement_6), S422-S434, 2019
262019
Kinesin motor domain of Leishmania donovani as a future vaccine candidate
A Dey, P Sharma, NS Redhu, S Singh
Clinical and Vaccine Immunology 15 (5), 836-842, 2008
252008
First case of indigenous visceral leishmaniasis from central India
A Dey, U Sharma, S Singh
The American journal of tropical medicine and hygiene 77 (1), 95-98, 2007
252007
Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection
JO Kim, S Rho, SH Kim, H Kim, HJ Song, EJ Kim, RY Kim, EH Kim, ...
Clinical and Vaccine Immunology 22 (4), 381-388, 2015
232015
A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi
N Kothari, S Kothari, YJ Choi, A Dey, DE Briles, DK Rhee, R Carbis
Vaccine 33 (6), 783-788, 2015
202015
Assessment of immunogenicity and protective efficacy of ZyCoV-D DNA vaccine candidates in Rhesus macaques against SARS-CoV-2 infection
PD Yadav, S Kumar, K Agarwal, M Jain, DR Patil, K Maithal, B Mathapati, ...
BioRxiv, 2021
182021
Use of immunoglobulin G avidity to determine the course of disease in visceral and post-kala-azar dermal leishmaniasis patients
NS Redhu, A Dey, V Balooni, S Singh
Clinical and vaccine immunology 13 (8), 969-971, 2006
182006
Enumeration of gut-homing β7-positive, pathogen-specific antibody-secreting cells in whole blood from enterotoxigenic Escherichia coli-and Vibrio cholerae-infected patients …
TR Bhuiyan, MR Hoq, NS Nishat, D Al Mahbuba, R Rashu, K Islam, ...
Clinical and Vaccine Immunology 23 (1), 27-36, 2016
122016
The system can't perform the operation now. Try again later.
Articles 1–20